Literature DB >> 6435795

Which patients are cured of breast cancer?

I S Fentiman, J Cuzick, R R Millis, J L Hayward.   

Abstract

The clinical and pathological features of 51 patients who survived for more than 20 years after diagnosis of cancer of the breast were compared with those of 176 contemporaries who died within 20 years after diagnosis. Of those who survived, 18 (35%) had had pathologically affected axillary nodes compared with at least 86 (49%) of those who died. Also, 11 (21%) of the survivors had had small tumours compared with 10 (6%) of those who died. Pathological review of tumours in the survivors showed 40 (78%) to have been infiltrating ductal carcinomas, of which 13 (32%) were grade 3 lesions. These differences between the two groups were largely due to the prognostic value of these variables in the first five years after diagnosis. After a patient had survived five years the major prognostic variables were of little value in the prediction of which patients would be cured of breast cancer. Advanced age, which was of little prognostic value in the first five years after diagnosis, was of significant prognostic value in the longer term, partly due to the steep age gradient for mortality from other diseases. Nevertheless, seven of 19 deaths more than 20 years after first treatment were due to breast cancer. Late deaths from breast cancer may, however, have often been the result of metastases from second primaries rather than the late manifestation of micrometastases from the original primary carcinoma. Age, menstrual state, clinical stage, and axillary nodes being affected are thus of some prognostic value in cancer of the breast, but the present inadequacy of knowledge of the behaviour of the disease makes accurate prediction of which patients will be cured impossible.

Entities:  

Mesh:

Year:  1984        PMID: 6435795      PMCID: PMC1443246          DOI: 10.1136/bmj.289.6452.1108

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  8 in total

1.  Control of cancer mortality.

Authors:  N E McKINNON
Journal:  Lancet       Date:  1954-01-30       Impact factor: 79.321

2.  Prognosis in breast cancer: the effect of age and menstrual status.

Authors:  A O Langlands; G R Kerr
Journal:  Clin Oncol       Date:  1979-06

3.  Long-term followup of breast cancer patients: the 30-year report.

Authors:  F Adair; J Berg; L Joubert; G F Robbins
Journal:  Cancer       Date:  1974-04       Impact factor: 6.860

4.  Long term survival analysis: the curability of breast cancer.

Authors:  S J Pocock; S M Gore; G R Kerr
Journal:  Stat Med       Date:  1982 Apr-Jun       Impact factor: 2.373

5.  The curability of breast cancer.

Authors:  D Brinkley; J L Haybrittle
Journal:  Lancet       Date:  1975-07-19       Impact factor: 79.321

6.  Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years.

Authors:  H J BLOOM; W W RICHARDSON
Journal:  Br J Cancer       Date:  1957-09       Impact factor: 7.640

7.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1976-12       Impact factor: 7.640

8.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

  8 in total
  5 in total

1.  Role of axillary dissection in breast cancer management.

Authors:  M Morrow
Journal:  Ann Surg Oncol       Date:  1996-05       Impact factor: 5.344

2.  A comparison of large block macrosectioning and conventional techniques in breast pathology.

Authors:  P A Jackson; W Merchant; C J McCormick; M G Cook
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

3.  Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort.

Authors:  J Cuzick; D M Berney; G Fisher; D Mesher; H Møller; J E Reid; M Perry; J Park; A Younus; A Gutin; C S Foster; P Scardino; J S Lanchbury; S Stone
Journal:  Br J Cancer       Date:  2012-02-23       Impact factor: 7.640

4.  Excess mortality from breast cancer 20 years after diagnosis when life expectancy is normal.

Authors:  W J Louwman; W J Klokman; J W Coebergh
Journal:  Br J Cancer       Date:  2001-03-02       Impact factor: 7.640

5.  Long-term survival in node-positive breast cancer treated by locoregional therapy alone.

Authors:  H Joensuu; L Pylkkänen; S Toikkanen
Journal:  Br J Cancer       Date:  1998-09       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.